ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers (i.e. home health, hospice, skilled nursing facilities, life plan communities, senior living centers, and private duty).
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| RMD | RESMED INC | 2025-10-16 21:19:37 | 268.01 | -1.99 | -0.74 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RMD | 0000943819 | RESMED INC | US7611521078 | 529900T3QE5253CCXF22 | 980152841 | NYSE | 3841 | Surgical & Medical Instruments & Apparatus | 0630 | DE | 9001 SPECTRUM CENTER BLVD. | SAN DIEGO | CA | 92123 | UNITED STATES | US | 8587462400 | 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123 | 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123 | — | Medical | 1989 | Michael "Mick" Farrell | 10,600 | http://resmed.com | 33,419,694,564 | 190,311,097 | 146,414,839 | ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers (i.e. home health, hospice, skilled nursing facilities, life plan communities, senior living centers, and private duty). | 2025-10-10 19:19:07 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 33,419,694,564 | 8,264,677,218 | 32.855 | 146,414,839 | -517,280 | -0.3521 |
| 2024 | 25,155,017,346 | -5,045,952,583 | -16.7079 | 146,932,119 | -139,285 | -0.0947 |
| 2023 | 30,200,969,929 | -7,570,171,071 | -20.0422 | 147,071,404 | 646,423 | 0.4415 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Mike Rider | Secretary, General Counsel | 2025 | 508,745 | — | 1,400,005 | 311,363 | 69,009 | 2,289,122 |
| Bobby Ghoshal | Chief Commercial Officer | 2025 | 651,660 | — | 2,400,078 | 550,001 | 50,716 | 3,652,455 |
| Michael Farrell | Chief Executive Officer | 2025 | 1,214,150 | — | 8,775,059 | 1,646,743 | 113,584 | 14,674,543 |
| Justin Leong | Chief Product Officer | 2025 | 677,032 | — | 2,600,037 | 552,478 | 81,894 | 3,911,441 |
| Brett Sandercock | Chief Financial Officer | 2025 | 498,967 | — | 2,600,037 | 407,171 | 65,835 | 3,572,010 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 10,600 |
| 2024 | 9,980 |
| 2023 | 10,140 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 5,146,327,000 | 4,685,297,000 | 4,222,993,000 |
| Cost Of Revenue | 2,091,357,000 | 2,029,994,000 | 1,867,331,000 |
| Gross Profit | 3,054,970,000 | 2,655,303,000 | 2,355,662,000 |
| Research And Development Expenses | 331,284,000 | 307,525,000 | 287,642,000 |
| General And Administrative Expenses | 991,019,000 | 917,136,000 | 874,003,000 |
| Operating Expenses | 1,369,607,000 | 1,335,410,000 | 1,223,791,000 |
| Operating Income | 1,685,363,000 | 1,319,893,000 | 1,131,871,000 |
| Net Income | 1,400,723,000 | 1,020,951,000 | 897,556,000 |
| Earnings Per Share Basic | 9.55 | 6.94 | 6.12 |
| Earnings Per Share Diluted | 9.51 | 6.92 | 6.09 |
| Weighted Average Shares Outstanding Basic | 146,716,000 | 147,021,000 | 146,765,000 |
| Weighted Average Shares Outstanding Diluted | 147,340,000 | 147,550,000 | 147,455,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 1,209,450,000 | 238,361,000 | 227,891,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 939,492,000 | 837,275,000 | 704,909,000 |
| Inventories | 927,711,000 | 822,250,000 | 998,012,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 164,498,000 | 180,012,000 | 179,925,000 |
| Total Assets Current | 3,505,605,000 | 2,357,719,000 | 2,367,830,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 550,790,000 | 548,025,000 | 537,856,000 |
| Other Assets Non Current | 185,839,000 | 284,001,000 | 262,453,000 |
| Total Assets Non Current | 550,790,000 | 548,025,000 | 537,856,000 |
| Total Assets | 8,174,391,000 | 6,872,394,000 | 6,751,708,000 |
| Accounts Payable | 278,157,000 | 237,728,000 | 150,756,000 |
| Deferred Revenue | 166,030,000 | 152,554,000 | 138,072,000 |
| Short Term Debt | 9,900,000 | 9,900,000 | 9,902,000 |
| Other Liabilities Current | 402,253,000 | 377,678,000 | 365,660,000 |
| Total Liabilities Current | 1,019,120,000 | 910,655,000 | 758,533,000 |
| Long Term Debt | 658,392,000 | 697,313,000 | 1,431,234,000 |
| Other Liabilities Non Current | 141,520,000 | 42,257,000 | 68,166,000 |
| Total Liabilities Non Current | 1,187,412,000 | 1,097,696,000 | 1,863,272,000 |
| Total Liabilities | 2,206,532,000 | 2,008,351,000 | 2,621,805,000 |
| Common Stock | 761,000 | 588,000 | 588,000 |
| Retained Earnings | 6,081,490,000 | 4,991,647,000 | 4,253,016,000 |
| Accumulated Other Comprehensive Income | -74,699,000 | -251,529,000 | -272,528,000 |
| Total Shareholders Equity | 5,967,859,000 | 4,864,043,000 | 4,129,903,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 198,473,000 | 176,870,000 | 165,156,000 |
| Share Based Compensation Expense | 91,661,000 | 80,184,000 | 71,142,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 76,684,000 | 134,278,000 | 106,511,000 |
| Change In Inventories | 80,165,000 | -172,203,000 | 248,833,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 90,958,000 | 122,072,000 | 31,342,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 1,751,588,000 | 1,401,260,000 | 693,299,000 |
| Purchases Of Marketable Securities | 6,416,000 | 12,765,000 | 32,229,000 |
| Sales Of Marketable Securities | 4,628,000 | 1,000,000 | 3,937,000 |
| Acquisition Of Property Plant And Equipment | 89,865,000 | 99,460,000 | 119,672,000 |
| Acquisition Of Business | 139,248,000 | 133,464,000 | 1,012,749,000 |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -200,045,000 | -269,784,000 | -1,159,845,000 |
| Tax Withholding For Share Based Compensation | 18,077,000 | 8,757,000 | 30,631,000 |
| Payments Of Dividends | 310,880,000 | 282,320,000 | 258,276,000 |
| Issuance Of Common Stock | 74,439,000 | 53,094,000 | 49,142,000 |
| Repurchase Of Common Stock | 300,025,000 | 150,011,000 | — |
| Issuance Of Long Term Debt | 0 | 105,000,000 | 1,070,000,000 |
| Repayment Of Long Term Debt | 40,000,000 | 835,000,000 | 405,000,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -606,253,000 | -1,119,287,000 | 422,874,000 |
| Change In Cash | 971,089,000 | 10,470,000 | -45,819,000 |
| Cash At End Of Period | 1,209,450,000 | 238,361,000 | 227,891,000 |
| Income Taxes Paid | 214,013,000 | 278,400,000 | 216,866,000 |
| Interest Paid | 28,415,000 | 45,708,000 | 47,379,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 9.55 | 6.94 | 6.12 |
| Price To Earnings Ratio | 27.0157 | 26.9366 | 35.7026 |
| Earnings Growth Rate | 37.6081 | 13.3987 | 14.6067 |
| Price Earnings To Growth Ratio | 0.7183 | 2.0104 | 2.4443 |
| Book Value Per Share | 40.6763 | 33.084 | 28.1396 |
| Price To Book Ratio | 6.3428 | 5.6505 | 7.7649 |
| Ebitda | 1,813,209,000 | 1,476,221,000 | 1,232,199,000 |
| Enterprise Value | 37,311,570,000 | 27,952,957,740 | 33,281,397,500 |
| Dividend Yield | 0.0082 | 0.0103 | 0.0081 |
| Dividend Payout Ratio | 0.2219 | 0.2765 | 0.2878 |
| Debt To Equity Ratio | 0.112 | 0.1454 | 0.349 |
| Capital Expenditures | 201,238,000 | 187,039,000 | 204,831,000 |
| Free Cash Flow | 1,550,350,000 | 1,214,221,000 | 488,468,000 |
| Return On Equity | 0.2347 | 0.2099 | 0.2173 |
| One Year Beta | 0.6363 | 1.293 | 0.7845 |
| Three Year Beta | 0.7828 | 0.8928 | 0.8346 |
| Five Year Beta | 0.816 | 0.961 | 0.9296 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Farrell Michael J. | Chief Executive Officer | 2025-10-07 | 8,009 | A | 475,801 |
| Farrell Michael J. | Chief Executive Officer | 2025-10-07 | 8,009 | D | 467,792 |
| Farrell Michael J. | Chief Executive Officer | 2025-10-07 | 8,009 | D | 8,011 |
| Rider Michael J | Global General Counsel | 2025-10-01 | 100 | D | 11,327 |
| Sandercock Brett | Chief Financial Officer | 2025-10-01 | 2,000 | A | 89,745 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Thomas H Tuberville | Senator | 2024-06-14 | Sale (Full) | 2024-05-03 | Joint | $1,001 - $15,000 |
| Thomas H Tuberville | Senator | 2023-11-16 | Purchase | 2023-10-17 | Joint | $1,001 - $15,000 |
| Thomas R Carper | Senator | 2023-09-05 | Purchase | 2023-08-29 | Spouse | $1,001 - $15,000 |
| Thomas R Carper | Senator | 2023-02-02 | Sale (Full) | 2023-01-11 | Spouse | $1,001 - $15,000 |
| Thomas H Tuberville | Senator | 2022-11-10 | Sale (Full) | 2022-10-05 | Joint | $1,001 - $15,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Kelly Louise Morrison | 2025-06-18 | MN03 | Sale | 2025-06-04 | — | $1,001 - $15,000 |
| Kelly Louise Morrison | 2025-06-18 | MN03 | Sale | 2025-06-04 | — | $1,001 - $15,000 |
| Kelly Louise Morrison | 2025-06-18 | MN03 | Sale | 2025-06-04 | — | $1,001 - $15,000 |
| Kelly Louise Morrison | 2025-06-18 | MN03 | Sale | 2025-06-04 | — | $1,001 - $15,000 |
| Kelly Louise Morrison | 2025-05-13 | MN03 | Sale | 2025-04-28 | — | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Carnegie Investment Counsel | 2025-09-30 | 1,316,915 | 4,811 | 273.73 |
| HENGEHOLD CAPITAL MANAGEMENT LLC | 2025-09-30 | 240,335 | 878 | 273.7301 |
| Capital Advisors, Ltd. LLC | 2025-09-30 | 56,000 | 204 | 274.5098 |
| Cohen Klingenstein LLC | 2025-09-30 | 1,615,007 | 5,900 | 273.73 |
| Signature Resources Capital Management, LLC | 2025-09-30 | 1,916 | 7 | 273.7143 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| Strategic Trust | 2025-08-31 | RUNNING OAK EFFICIENT GROWTH ETF | RUNN | 26,100 | 7,164,711 | 1.8875 |
| TRUST FOR PROFESSIONAL MANAGERS | 2025-08-31 | Column Mid Cap Fund | CFMCX | 2,878 | 790,039.78 | 0.0793 |
| ETF Series Solutions | 2025-07-31 | Aptus Large Cap Enhanced Yield ETF | DUBS | 418 | 113,670.92 | 0.0475 |
| Pacer Funds Trust | 2025-07-31 | Pacer US Large Cap Cash Cows Growth Leaders ETF | COWG | 85,079 | 23,136,383.26 | 0.995 |
| Pacer Funds Trust | 2025-07-31 | Pacer Trendpilot US Large Cap ETF | PTLC | 9,122 | 2,480,636.68 | 0.0743 |